AGIOS PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Basic Shares Outstanding (Weighted Average) of 59.49 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 59.49M shares, a 2.69% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 58.78M shares, a 2.30% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 58.35M shares, a 2.19% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 58.14M shares, a 2.11% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 57.97M shares, a 2.05% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 56.81M shares, a 2.08% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 55.65M shares, a 1.57% increase from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 54.79M shares, a 9.36% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 59.49M shares 10-Q · filed 2026-07-30 | 59.14M shares 10-Q · filed 2026-07-30 | 58.87M shares derived: average of 3 quarters · filed 2026-07-30 | 58.69M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 58.78M shares 10-Q · filed 2026-04-29 | 58.57M shares derived: average of 2 quarters · filed 2026-04-29 | 58.42M shares derived: average of 3 quarters · filed 2026-04-29 | 58.30M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | 58.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 58.24M shares derived: average of 2 quarters · filed 2026-02-12 | 58.14M shares derived: average of 3 quarters · filed 2026-07-30 | 57.97M shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 58.14M shares 10-Q · filed 2025-10-30 | 58.04M shares derived: average of 2 quarters · filed 2026-07-30 | 57.85M shares 10-Q · filed 2025-10-30 | 57.66M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | 57.93M shares 10-Q · filed 2026-07-30 | 57.70M shares 10-Q · filed 2026-07-30 | 57.50M shares derived: average of 3 quarters · filed 2026-07-30 | 57.36M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | 57.46M shares 10-Q · filed 2026-04-29 | 57.28M shares derived: average of 2 quarters · filed 2026-04-29 | 57.17M shares derived: average of 3 quarters · filed 2026-04-29 | 57.08M shares derived: average of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | 57.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 57.02M shares derived: average of 2 quarters · filed 2026-02-12 | 56.95M shares derived: average of 3 quarters · filed 2026-02-12 | 56.81M shares 10-K · filed 2026-02-12 |
| 2024-09-30 | 56.94M shares 10-Q · filed 2025-10-30 | 56.87M shares derived: average of 2 quarters · filed 2025-10-30 | 56.71M shares 10-Q · filed 2025-10-30 | 56.51M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | 56.80M shares 10-Q · filed 2025-07-31 | 56.59M shares 10-Q · filed 2025-07-31 | 56.37M shares derived: average of 3 quarters · filed 2026-02-12 | 56.23M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | 56.38M shares 10-Q · filed 2025-05-01 | 56.16M shares derived: average of 2 quarters · filed 2026-02-12 | 56.04M shares derived: average of 3 quarters · filed 2026-02-12 | 55.93M shares derived: average of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | 55.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 55.87M shares derived: average of 2 quarters · filed 2026-02-12 | 55.78M shares derived: average of 3 quarters · filed 2026-02-12 | 55.65M shares 10-K · filed 2026-02-12 |
| 2023-09-30 | 55.80M shares 10-Q · filed 2024-10-31 | 55.70M shares derived: average of 2 quarters · filed 2024-10-31 | 55.56M shares 10-Q · filed 2024-10-31 | 55.41M shares derived: average of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | 55.60M shares 10-Q · filed 2024-08-01 | 55.44M shares 10-Q · filed 2024-08-01 | 55.27M shares derived: average of 3 quarters · filed 2025-02-13 | 55.17M shares derived: average of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | 55.27M shares 10-Q · filed 2024-05-02 | 55.11M shares derived: average of 2 quarters · filed 2025-02-13 | 55.02M shares derived: average of 3 quarters · filed 2025-02-13 | 54.97M shares derived: average of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | 54.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 54.90M shares derived: average of 2 quarters · filed 2025-02-13 | 54.87M shares derived: average of 3 quarters · filed 2025-02-13 | 54.79M shares 10-K · filed 2025-02-13 |
| 2022-09-30 | 54.84M shares 10-Q · filed 2023-11-02 | 54.82M shares derived: average of 2 quarters · filed 2023-11-02 | 54.73M shares 10-Q · filed 2023-11-02 | 54.62M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | 54.80M shares 10-Q · filed 2023-08-03 | 54.68M shares 10-Q · filed 2023-08-03 | 54.55M shares derived: average of 3 quarters · filed 2024-02-15 | 55.17M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | 54.56M shares 10-Q · filed 2023-05-04 | 54.42M shares derived: average of 2 quarters · filed 2024-02-15 | 55.29M shares derived: average of 3 quarters · filed 2024-02-15 | 56.74M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | 54.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 55.66M shares derived: average of 2 quarters · filed 2024-02-15 | 57.47M shares derived: average of 3 quarters · filed 2024-02-15 | 60.45M shares 10-K · filed 2024-02-15 |
| 2021-09-30 | 57.05M shares 10-Q · filed 2022-11-03 | 59.06M shares derived: average of 2 quarters · filed 2022-11-03 | 62.50M shares 10-Q · filed 2022-11-03 | 64.23M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 61.07M shares 10-Q · filed 2022-08-04 | 65.28M shares 10-Q · filed 2022-08-04 | 66.63M shares derived: average of 3 quarters · filed 2023-02-23 | 67.26M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 69.54M shares 10-Q · filed 2022-05-05 | 69.41M shares derived: average of 2 quarters · filed 2023-02-23 | 69.32M shares derived: average of 3 quarters · filed 2023-02-23 | 69.23M shares derived: average of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 69.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 69.21M shares derived: average of 2 quarters · filed 2023-02-23 | 69.13M shares derived: average of 3 quarters · filed 2023-02-23 | 69.00M shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 69.14M shares 10-Q · filed 2021-11-03 | 69.05M shares derived: average of 2 quarters · filed 2021-11-03 | 68.91M shares 10-Q · filed 2021-11-03 | |
| 2020-06-30 | 68.96M shares 10-Q · filed 2021-07-29 | 68.78M shares 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | 68.61M shares 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | 59.99M shares 10-K · filed 2022-02-24 | |||
| 2015-09-30 | 37.51M shares 10-Q · filed 2015-11-06 | 37.35M shares 10-Q · filed 2015-11-06 | ||
| 2014-09-30 | 34.50M shares 10-Q · filed 2015-11-06 | 33.18M shares 10-Q · filed 2015-11-06 | ||
| 2013-09-30 | 22.74M shares 10-Q · filed 2014-11-07 | 10.11M shares 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |